Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Skeletal Myoblasts for Ischemic Cardiomyopathy
NCT00626314Phase 2Unknown
- Sponsor
- Mytogen
- Start
- Mar 2008
- Primary completion
- Mar 2010
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous skeletal myoblasts in ischemic cardiomyopathy (ICM), heart failure (HF), sponsored by Mytogen. Status: unknown.
02
Drugs
autologous skeletal myoblasts
03
Conditions
ischemic cardiomyopathy (ICM)heart failure (HF)
Beyond the preview
Go deeper on NCT00626314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626314.